Development of a Dry-Reagent Nucleic Acid Detection Platform Using Thermostabilized LATE-PCR and Lateral Flow Biosensor

Introduction to Modern Molecular Diagnostics

Accurate and timely diagnosis is a cornerstone of modern healthcare systems, enabling evidence-based treatment decisions and reducing the risks associated with misdiagnosis, including increased morbidity and mortality. Traditional microbiological diagnostic approaches, particularly culture-based methods, remain the gold standard for bacterial identification. However, these techniques are inherently time-consuming and require strict specimen handling and transport conditions to maintain microbial viability.

To overcome these limitations, nucleic acid amplification-based diagnostic methods have emerged as powerful alternatives in routine microbiology laboratories. These techniques offer significant advantages, including high sensitivity, specificity, faster turnaround time, and operational robustness, making them increasingly valuable for pathogen detection and disease monitoring.

Rise of Lateral Flow Biosensors in Nucleic Acid Detection

In recent years, lateral flow (dipstick-type) biosensors have gained attention as efficient post-amplification tools for detecting nucleic acid targets. These systems eliminate the need for labor-intensive agarose gel electrophoresis and specialized equipment, simplifying the workflow.

Key advantages of lateral flow biosensors include:

  • Rapid visual readout without instrumentation
  • Ease of use and minimal training requirements
  • Stability at room temperature
  • Low production cost and accessibility
  • Suitability for point-of-care and field applications

Due to these features, lateral flow technologies have expanded beyond clinical diagnostics into areas such as:

  • Food safety and water quality monitoring
  • Agriculture and aquaculture
  • Veterinary diagnostics
  • Environmental surveillance
  • Biosecurity and public health

Types of Nucleic Acid Lateral Flow Assays

Nucleic acid-based lateral flow systems are generally classified into two main categories:

1. Nucleic Acid Lateral Flow Immunoassay (NALFIA)

NALFIA detects labeled double-stranded DNA amplicons through antigen–antibody interactions. While it offers rapid detection, it is prone to false-positive results due to non-specific binding. Enhancements such as coupling with primer extension (PEXT) reactions improve specificity but introduce additional steps and complexity.

2. Nucleic Acid Lateral Flow (NALF)

NALF systems rely on sequence-specific hybridization between target DNA and immobilized capture probes on the test strip. Although more specific, earlier implementations required elevated temperatures and were not compatible with dry-reagent formats, limiting their field applicability.

Innovative Integration: Thermostabilized LATE-PCR with NALF

To address existing limitations, a novel nucleic acid-sensing platform has been developed by integrating:

  • Thermostabilized LATE-PCR (Linear-After-The-Exponential PCR)
  • Sequence-specific lateral flow biosensor (NALF)

This system is specifically designed for the detection of the ctxA gene of toxigenic Vibrio cholerae, a pathogen responsible for cholera outbreaks and global public health concerns.

Advantages of Thermostabilized LATE-PCR

LATE-PCR is an advanced asymmetric PCR technique optimized for generating single-stranded DNA (ssDNA), which is ideal for hybridization-based detection. Key benefits include:

  • High amplification efficiency
  • Improved signal-to-noise ratio
  • Reduced interference from non-target sequences
  • Capability for multiplex detection
  • Integration of internal amplification controls (IAC)

The thermostabilization and lyophilization (freeze-drying) of the PCR reagents convert the assay into a dry-reagent format, offering several operational advantages:

  • Elimination of cold chain requirements
  • Enhanced stability at varying temperatures
  • Reduced risk of contamination
  • Simplified workflow with minimal pipetting steps

Design and Function of the Lateral Flow Biosensor

The lateral flow biosensor operates through in situ hybridization at ambient temperature (20–25°C). The detection process involves:

  1. Hybridization between fluorescently labeled ssDNA amplicons and immobilized capture probes
  2. Migration of gold nanoparticle conjugates via capillary action
  3. Formation of visible red/pink lines indicating target presence

Result Interpretation

  • Positive result: Appearance of a test line (with or without IAC line)
  • Negative result: Absence of test line but presence of IAC line
  • Invalid result: Absence of both test and IAC lines
  • Control line: Confirms proper assay function

Performance and Analytical Capabilities

The developed platform demonstrates high analytical performance, including:

  • Limit of detection (LOD) as low as:
    • 1 pg of genomic DNA
    • 10 CFU/mL bacterial concentration
  • High specificity, with no cross-reactivity observed against non-target bacterial strains
  • Excellent reproducibility, confirmed through repeated testing
  • 100% sensitivity and specificity when validated using clinical and environmental samples

Thermal Stability and Field Applicability

One of the most significant advancements of this platform is its robust thermal stability:

  • Stable for up to 90 days at 4–37°C
  • Maintains functionality for at least 30 days at 56°C

This eliminates the need for refrigeration, making the system highly suitable for:

  • Resource-limited settings
  • Remote and field diagnostics
  • Outbreak surveillance and rapid response

Applications in Public Health and Diagnostics

The dry-reagent LATE-PCR-NALF platform has broad applications, including:

  • Rapid detection of infectious diseases
  • Cholera surveillance and outbreak investigation
  • Environmental and water quality monitoring
  • Point-of-care diagnostics in low-resource settings

Its ability to combine molecular accuracy with operational simplicity positions it as a powerful tool for expanding access to advanced diagnostic technologies globally.

Conclusion

The integration of thermostabilized LATE-PCR with a lateral flow biosensor represents a significant advancement in nucleic acid detection technologies. By combining high sensitivity, sequence specificity, thermal stability, and user-friendly design, this platform addresses major limitations of conventional diagnostic methods. Its dry-reagent format and cold chain independence make it particularly valuable for decentralized testing environments, paving the way for more accessible and reliable molecular diagnostics worldwide.